AREV Life Sciences Global Corp
CNSX:AREV
Cash Flow Statement
Cash Flow Statement
AREV Life Sciences Global Corp
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(8)
|
(8)
|
(10)
|
(9)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
1
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
1
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
(0)
|
(0)
|
(0)
|
|
| Other Non-Cash Items |
7
|
7
|
8
|
8
|
2
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
(0)
|
(0)
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
(0)
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
+3%
|
(1)
+29%
|
(1)
+1%
|
(0)
+85%
|
0
N/A
|
(0)
N/A
|
(0)
-75%
|
(0)
+84%
|
(1)
-2 387%
|
(1)
-86%
|
(1)
-3%
|
(1)
-32%
|
(1)
+23%
|
(0)
+62%
|
(0)
+13%
|
0
N/A
|
0
+9%
|
0
-10%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Other Items |
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+33%
|
(0)
+4%
|
0
N/A
|
(0)
N/A
|
(0)
+64%
|
(0)
+10%
|
(0)
+46%
|
(0)
-1 057%
|
0
N/A
|
0
+17%
|
0
-7%
|
0
-72%
|
(0)
N/A
|
(0)
0%
|
(0)
0%
|
0
N/A
|
0
+145%
|
0
+20%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
1
N/A
|
1
+17%
|
1
+1%
|
1
-26%
|
0
-37%
|
0
-33%
|
0
-16%
|
0
-6%
|
1
+290%
|
1
+26%
|
1
+3%
|
1
+1%
|
1
+35%
|
1
-27%
|
1
-9%
|
1
-2%
|
0
-98%
|
(0)
N/A
|
(0)
+32%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
(1)
N/A
|
(1)
+32%
|
(0)
+47%
|
(0)
+47%
|
0
N/A
|
0
+698%
|
0
-75%
|
(0)
N/A
|
0
N/A
|
0
+82%
|
0
-92%
|
0
-76%
|
(0)
N/A
|
(1)
-404%
|
(0)
+89%
|
(0)
+47%
|
0
N/A
|
0
-14%
|
0
+12%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(1)
-6%
|
(1)
+20%
|
(1)
+2%
|
(0)
+65%
|
(0)
+44%
|
(0)
-50%
|
(0)
-12%
|
(0)
-40%
|
(1)
-113%
|
(1)
-52%
|
(1)
-3%
|
(1)
-4%
|
(1)
+21%
|
(0)
+60%
|
(0)
+12%
|
0
N/A
|
0
+32%
|
0
0%
|
|